BioRestorative Therapies Short Interest Ratio and Short Volume

Short interest is the volume of BioRestorative Therapies shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 100 shares of BRTX short. 0.00% of BioRestorative Therapies' shares are currently sold short. View details.

BioRestorative Therapies saw a decrease in short interest in December. As of December 31st, there was short interest totaling 100 shares, a decrease of 99.8% from the previous total of 49,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of BioRestorative Therapies' shares are currently sold short. Here is how the short interest of companies in the industry of "miscellaneous health & allied services, not elsewhere classified" compare to BioRestorative Therapies: Fresenius Medical Care AG & Co. KGaA (0.00%), DaVita Inc. (4.79%), Progyny, Inc. (7.02%), Ontrak, Inc. (39.81%), Tivity Health, Inc. (18.92%), American Renal Associates Holdings, Inc. (3.29%), Viemed Healthcare, Inc. (3.89%), Cryo-Cell International, Inc. (0.00%), Baudax Bio, Inc. (4.85%), and Emmaus Life Sciences, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

Short selling BRTX is an investing strategy that aims to generate trading profit from BioRestorative Therapies as its price is falling. To short BioRestorative Therapies stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that BioRestorative Therapies will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioRestorative Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BRTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRTX, twice per month. The most recent reporting period available is December, 31 2020.